Showing results (901-910 of 2,363) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|January 23, 2018
Common structural and pharmacophoric features of mPGES-1 and LTC4SNisha S Devi, Padmapriya Paragi-Vedanthi, Andreas Bender, et al.
Future Medicinal Chemistry|May 13, 2022
Synthesis and in vitro studies for structure-based design of novel chalcones as antitubercular agents targeting InhALoganathan S Dhivya, Balappaudayar R Pradeepa, Sabarathinam Sarvesh
Future Medicinal Chemistry|May 10, 2022
Factorial design in the optimization and study 'in combo' of derivatives of imidazo[1,2-a]azines in the COX´s isoforms inhibitionMiguel Guerrero-González, María-Elena Campos Aldrete, Marco Antonio Meraz-Rios
Future Medicinal Chemistry|May 31, 2022
9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitorsWenyan Wang, Shilan Lin, Guangying Du, et al.
Future Medicinal Chemistry|July 7, 2021
Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitorsYongtao Xu, Yunlong Gao, Min Yang, et al.
Future Medicinal Chemistry|July 9, 2021
Structural characteristics of small-molecule inhibitors targeting FTO demethylaseShuting Gao, Xitong Li, Miao Zhang, et al.
Future Medicinal Chemistry|June 2, 2021
Antibacterial properties and carbonic anhydrase inhibition profiles of azido sulfonyl carbamate derivativesPınar Güller, Ufuk Atmaca, Uğur Güller, et al.
Future Medicinal Chemistry|January 8, 2021
Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product databaseJurica Novak, Hrvoje Rimac, Shivananda Kandagalla, et al.
Future Medicinal Chemistry|July 2, 2021
Molecular modeling studies of [4-(3H-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine-based CDK4 inhibitorsHan Lv, Yongli Du, Xiehuang Sheng, et al.
Future Medicinal Chemistry|June 28, 2021
Discovery of novel STAT3 DNA binding domain inhibitorsBocheng Wu, Benny Payero, Sydney Taylor, et al.
Pageof 237